Skip to main content

David Soler Segovia

Institutions of which they are part

Predoctoral researcher
Pneumology
Vall Hebron Institut de Recerca

David Soler Segovia

Institutions of which they are part

Predoctoral researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Caracterización y factores de riesgo de las SEcuelas PULmonares de los pacientes que superan una neumonía por COVID-19 (PULSE-COVID).

IP: Fco. Javier Muñoz Gall
Collaborators: Maria Angeles Jiménez Fuentes, Marc Miravitlles Fernández, David Clofent Alarcón, David Soler Segovia
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI21/01046
Duration: 01/01/2022 - 31/12/2025

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome (EXIMIOUS)

IP: Mª Jesús Cruz Carmona
Collaborators: Fco. Javier Muñoz Gall, David Espejo Castellanos, David Soler Segovia, Ana Villar Gomez
Funding agency: EUROPEAN COMMISSION
Funding: 395500
Reference: EXIMIOUS_H2020_SC1-BHC-2019
Duration: 01/01/2020 - 30/06/2025

Related news

ISMED-CLIM is a European project coordinated by the University of Cyprus and has 27 partners from 11 countries, including the Parc Sanitari Pere Virgili and the Vall d'Hebron Research Institute, which lead the regional working group.

The Cystic Fibrosis Unit is leading research into new genetic treatments for the disease.

The EXPOSIM project will investigate the impact of environmental stressors such as pollution, noise and aeroallergens on immune-mediated diseases.

Related professionals

Eulalia Gine Cipres

Eulalia Gine Cipres

Headache and Neurological Pain
Read more
Carles Bravo Masgoret

Carles Bravo Masgoret

Pneumology
Read more
Yoursa El-Kasmy El Kasmi

Yoursa El-Kasmy El Kasmi

Administration and Management
General Surgery
Read more
Marc Ferrer Vinardell

Marc Ferrer Vinardell

Main researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.